Hydroxyurea: what it is. New Mexico AIDS InfoNet.

  • Published 1998 in Newsline

Abstract

Hydroxyurea (Hydrea) is an antiviral drug approved for use against cancer and sickle cell anemia. Produced by Bristol-Myers Squibb, it has not yet received Food and Drug Administration (FDA) approval for use against HIV; however, trial results are promising. The drug works by blocking a human cell enzyme used to multiply cells, and appears to be most… (More)

Topics

  • Presentations referencing similar topics